Company filings profile · CIK 0001339970
ATYR PHARMA INC — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for ATYR PHARMA INC (ATYR): 13 filings in the last 90 days vs 14 in the prior 90 (filing-velocity steady · 0.93×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 17, 2026. Source-linked, daily-refreshed.
Material 8-K events — ATYR PHARMA INC
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 16, 2026 | Item 5.07 | ↗ |
| Sep 24, 2026 | Other Events | ↗ |
| Aug 7, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 31, 2026 | Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jun 8, 2026 | Delisting / Listing-Rule Failure | ↗ |
| Jun 1, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 11, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch ATYR PHARMA INC automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 16, 2026 | 8-K | Item 5.07 | ↗ |
| Oct 7, 2026 | SCHEDULE 13G/A | ↗ | |
| Oct 1, 2026 | 4 | 4 | ↗ |
| Oct 1, 2026 | 3 | 3 | ↗ |
| Sep 24, 2026 | 8-K | Other Events | ↗ |
| Sep 11, 2026 | DEF 14A | DEF 14A | ↗ |
| Aug 31, 2026 | PRE 14A | PRE 14A | ↗ |
| Aug 7, 2026 | S-8 | S-8 | ↗ |
| Aug 7, 2026 | 10-Q | 10-Q | ↗ |
| Aug 7, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 31, 2026 | 8-K | Termination of a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 27, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 8, 2026 | SCHEDULE 13G/A | ↗ | |
| Jun 8, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Jun 5, 2026 | SCHEDULE 13G/A | ↗ | |
| Jun 1, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 28, 2026 | 4 | 4 | ↗ |
| May 15, 2026 | 10-Q | 10-Q | ↗ |
| May 15, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 13, 2026 | 4 | 4 | ↗ |
| May 13, 2026 | 4 | 4 | ↗ |
| May 13, 2026 | 4 | 4 | ↗ |
| May 13, 2026 | 4 | 4 | ↗ |
| May 13, 2026 | 4 | 4 | ↗ |
| May 13, 2026 | 4 | 4 | ↗ |
| May 11, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 26, 2026 | ARS | ARS | ↗ |
| Mar 26, 2026 | DEFA14A | DEFA14A | ↗ |
| Mar 26, 2026 | SCHEDULE 13G/A | ↗ | |
| Mar 26, 2026 | DEF 14A | DEF 14A | ↗ |
| Mar 12, 2026 | PRE 14A | PRE 14A | ↗ |
| Mar 5, 2026 | 10-K | 10-K | ↗ |
| Mar 5, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Feb 4, 2026 | 4 | 4 | ↗ |
| Feb 4, 2026 | 4 | 4 | ↗ |
| Feb 4, 2026 | 4 | 4 | ↗ |
| Jan 9, 2026 | 4 | 4 | ↗ |
| Jan 9, 2026 | 4 | 4 | ↗ |
| Jan 9, 2026 | 4 | 4 | ↗ |